Healthcare & Public Health

The need for scalable, efficient manufacturing of vaccines and therapeutics has increased. Ginkgo’s biomanufacturing infrastructure enables large-scale production of vaccines and treatments, facilitating agency goals to improve health resilience and rapid deployment of medical countermeasures during outbreaks.

Precision medicine requires targeted therapies, often involving advanced genomic insights. Ginkgo’s genome editing capabilities, supported by AI-driven optimization, enable customized microbial and cellular solutions that align with agency priorities in personalized medicine and genomic surveillance to track evolving pathogens.

Equitable healthcare access and robust biosecurity each present ever-evolving challenges to the public and private sectors alike. Ginkgo’s biosensing networks support widespread, real-time pathogen monitoring in underserved areas, ensuring biosecurity in regions with limited access to medical infrastructure. This capability promotes early intervention across diverse populations and mitigates disparities in health outcomes.

AI and data analytics are prioritized by health agencies for improving insights and decision-making. Ginkgo’s AI-driven data platforms support genomic analysis and disease modeling, helping the government better understand pathogen behavior and effectiveness of treatments across different population groups.

Agencies focus on strengthening rapid response to emerging infectious diseases through advanced diagnostics, vaccines, and treatment options. Ginkgo’s high-throughput platforms and biosensing technologies support this by enabling real-time pathogen detection and fast-tracked vaccine development—critical for managing infectious threats​.